Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Bio Path Holdings Inc BPTH

Healthcare Biotechnology
Bio-Path Holdings, Inc. is a biotechnology company. The Company is engaged in developing DNAbilize, a novel technology that has yielded a pipeline of RNAi nanoparticle drugs that can be administered with a simple intravenous transfusion. DNAbilize, is a platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification that is intended to protect the DNA from destruction... see more

Bullboard (NDAQ:BPTH)

View:
1 2 3 Next
Post by Iseneschalon Aug 21, 2024 10:03am

BPTH....volume & price action...why u ask ?

Warrants are being exercised.....save ur money tm2412459-1_s1 - none - 4.4375097s (sec.gov)
20
Post by whytestockson Jul 08, 2024 1:00pm

Bio-Path Holdings Provides Clinical Update and Expansion Pla

BREAKING NEWS: $BPTH Bio-Path Holdings Provides Clinical Update and Expansion PlansMarks Meaningful Progress Across Key Clinical Trials in Multiple Cancer Indications Completes Development of Oncology ...more  
34
Post by whytestockson Jun 04, 2024 5:45pm

Bio-Path Holdings Announces $4.0 Million Private Placement P

JUST IN: $BPTH Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesHOUSTON, June 04, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ:BPTH) (& ...more  
56
Post by Iseneschalon Jun 04, 2024 8:53am

BPTH.... You've all been had .... Again !!!!

What a game. That's what you get for being a "Greater Fool" ...otherwise known as a Chaser!!!! Cheers !
30
Comment by Iseneschalon Jun 04, 2024 8:50am

RE:BPTH.....way too much volume this a.m......

I won the bet ......here is the P.O announcement :   Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules   2024-06-04 05:00 ET - News ...more  
33
Discussion
Post by Iseneschalon Jun 03, 2024 10:35am

BPTH...... N.L.O.D

LoL LoL LoL All the a.m opening Chasers got their heads handed back to them in a hand-basket over 44 million shares have traded.....and all it's up is a buck.....Whats wrong with this picture !! ...more  
56
Comment by Iseneschalon Jun 03, 2024 9:57am

RE:BPTH.....Short set up here....JMHO

Not too bags......shorted into the opening strength while the MM was giving as much paper he could to all the Chasers Just covered......for almost a $1 profit per share....Thank you !!!
29
Discussion
Post by Iseneschalon Jun 03, 2024 9:25am

BPTH.....Short set up here....JMHO

Waiting for the opening pump to bury all the Chasers ; )
79
Discussion
Post by Iseneschalon Jun 03, 2024 9:21am

BPTH.....way too much volume this a.m......

THis will get very ugly because this is a pump being set up for a P.O ....betcha ; ) Currently at $4 on 12.6 million shares
79
Discussion
Post by Iseneschalon Jun 03, 2024 9:18am

BPTH.....Early a.m runner on NR this a.m

Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual Meeting 2024-06 ...more  
53
1 2 3 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities